Clinical Trials Browser

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT05477576 2026-03-30

ACTION-1

Phase 3 Recruiting

338 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT07087054 2026-03-10

CAREFNDR

Phase 3 Recruiting

141 enrolled

EndocrineNET

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT05918302 2026-03-06

LEVEL

Phase 3 Recruiting

120 enrolled

EndocrineNET

Thymus Neoplasms, Neuroendocrine Tumors

NCT04706910 2026-02-09

18F-DOPA II - PET Imaging Optimization

Phase 3 Recruiting

800 enrolled

CNSEndocrineNET

Brain Neoplasms, Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Lewy Body Disease, Congenital Hyperinsulinism

NCT07185672 2025-09-22

PReCedeNT

Phase 3 Recruiting

162 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT05387603 2025-09-10

START-NET

Phase 3 Recruiting

300 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT06878664 2025-09-02

RIALTO

Phase 3 Recruiting

166 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT04847505 2024-07-18

68Ga-DOTA-TATE PET/CT Imaging in NETs

Phase 3 Recruiting

5,000 enrolled

EndocrineNET

Neuroendocrine Tumors

Clinical Trials

Tumor HI

ACTION-1

CAREFNDR

LEVEL

18F-DOPA II - PET Imaging Optimization

PReCedeNT

START-NET

RIALTO

68Ga-DOTA-TATE PET/CT Imaging in NETs